Site US10009 — Philadelphia, Pennsylvania

Site US10009 is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Site US10009 has participated in 1 clinical trials.

Therapeutic areas: Non-Small-Cell Lung Cancer (NSCLC), Epidermal Growth Factor Receptor Mutations.

Sponsors: Astellas Pharma Global Development, Inc..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site US10009?

Site US10009 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site US10009 conducted?

Site US10009 has 1 clinical trials on record. Their work covers Non-Small-Cell Lung Cancer (NSCLC), Epidermal Growth Factor Receptor Mutations.

Is Site US10009 accredited by Crixeo Health?

Site US10009 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site US10009?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.